chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 month old patient received a dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number T343J, expiry date 25-JAN-2025) for prophylaxis.   On 19-OCT-2023, the patient received Kinrix. On 19-OCT-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 4 month old patient received a dose of Kinrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-OCT-2023 The reporter informed that a 4 month old patient received a dose of Kinrix which led to inappropriate age at vaccine administration. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter.
A report was received from a health care professional on 22OCT2003 concerning a 9 month old female vaccinee who received Fluvirin on 22OCT2003. On 22OCT2003 the 9 month old vaccinee received Fluvirin. The vaccinee had not experienced any adverse symptoms at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1 17NOV2003: Follow up information received from a health care professional indicated that the vaccinee did not experience any adverse effects.
I just want to be on record that on September 5, 2021 I had a heart attack. I don't know if it is as a result of the vaccine, but I think a study should be made of heart attacks after the vaccine. I go to the doctors yearly for physicals, I had a stress test less than a year before. I only had high blood pressure, which was under control. No heart disease in my family. My cholesterol and sugar were always almost borderline.  I am seriously concerned that the vaccine may have somehow been a cause in some way. I have heard rumor of increased plaque buildup due to the vaccine.
High blood sugar; This case was reported by a pharmacist via call center representative and described the occurrence of blood sugar increased in a 78-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 15th July 2019, the patient received Boostrix (intramuscular). In July 2019, less than a week after receiving Boostrix, the patient experienced blood sugar increased. On an unknown date, the outcome of the blood sugar increased was unknown.   It was unknown if the reporter considered the blood sugar increased to be related to Boostrix.  Additional details were provided as follows: The patient blood sugar was high. The patient did not report to pharmacist when the blood sugar changes occurred. The reporter consented to follow up. The reporter stated that he had no further details available at the time of reporting, however he gave permission for safety to follow up.
Patient came into the pharmacy today 11/21/14, and talked to tech and pharmacist claiming that she could not use her left arm. She now had to seek physical therapy for it. She stated that I injected her FLUZONE HD in her upper back. This is not true. I administered 2 shots 10/10/14 around 7 pm. One was her and one to her husband. She states I injected her husband in the left arm and for some reason I injected her in her back. She never reported any redness at the site of injection. This is the 1st time I heard from her. Given her husband and her left the store they are not okay. I had to chase them down to give them.
Patient came into our healthcare facility on 01/08/2022 asking for the first dose of Pfizer vaccine to be administered. On his consent form, patient agreed and signed to not receiving a COVID vaccine in the past. Patient was given his first dose of Pfizer vaccine that day. Patient then returned to our facility for his second dose three weeks later on 01/29/2022. After administering another dose of the Pfizer vaccine, patient informed the front desk that his one of the portions of his name is actually a part of his first name instead of his last name. This was changed on his vaccination record card by our staff. Patient was then checked to update his contact information which is when we found patient's chart containing a first dose of the Pfizer vaccine that was given on 09/25/2021. The patient was informed of this error.  He was told to wait 15 minutes in the facility and to return to our facility if he experiences any additional symptoms.
Mom of pt concerned about possible reactions to 2nd flu vaccine 12/26/14 at nurse visit apptmt. Rash occurred approximately 2-3 days after immunization given. Mom presented to HC with pictures taken by her cell phone . According to photos, reddened rash to cheeks, BLE and BUE noted. Current today assessment (1/5/2015) reveals no redness to cheeks. BLE/BUE skin dryness/roughness noted. denies fever. No SOB or acute distress noted. No treatment necessary at this time, as mom stated that she is applying lotion to site for the dryness. Advised mom to contact HC in the morning at 8:30am if rash re-appears.
PT FEELS DIZZY AND DEHYDRATED, BP WAS TAKEN. BP WAS 122/71, HR WAS 73. ON SECOND READING BP WAS 123/74, HR WAS 64
chest pain; high blood pressure; soreness; terrible shoulder pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (terrible shoulder pain), MYALGIA (soreness), CHEST PAIN (chest pain) and HYPERTENSION (high blood pressure) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced ARTHRALGIA (terrible shoulder pain). On 19-Feb-2021, the patient experienced MYALGIA (soreness). On 22-Feb-2021, the patient experienced HYPERTENSION (high blood pressure). On 24-Feb-2021, the patient experienced CHEST PAIN (chest pain). On 23-Jan-2021, ARTHRALGIA (terrible shoulder pain) outcome was unknown. At the time of the report, MYALGIA (soreness), CHEST PAIN (chest pain) and HYPERTENSION (high blood pressure) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Electrocardiogram: normal.         Upon internal review on 21-May-2021, the age was corrected to unknown.   This case was linked to MOD21-041389 (Patient Link).
Went to bed turned over onto arm and felt like I'd been hit with a 2x4. It was swollen and red barely slept all night next day could not raise my arm could barely move it at all plus I had aches and pain thru entire body I felt like I'd been hit by a mack truck. It started late that Friday night and lasted all thru Sunday. I started feeling better that Monday but my arm was still sore for a couple more days
Temp 99'O' 2 inch diameter reddened raised area, warm to touch on R deltoid.  Motrin given per parent.
No adverse reaction reported; The patient received one dose of VAQTA on 04-APR-2019 that expired on 02-APR-2019; This spontaneous report was received from office manager refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 04-APR-2019, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (lot # R006471, expiry date: 02-APR-2019) 1 dosage form via intramuscular route for prophylaxis (expired product administered). The product had no previous temperature excursions. No adverse reaction reported (no adverse event). No additional information provided. No product quality complaint (PQC) was involved. The outcome of expired product administered, and no adverse event was unknown.
J&J vaccine was received yesterday afternoon. Pt c/o headache, bodyache and n/d. HPI:20-year-old male with chief complaint of fever headache and body aches after receiving the Johnson & Johnson vaccine yesterday.  He has not taken anything for his symptoms.  He denies any belly pain nausea or vomiting.
tested positive for COVID/started with symptoms, fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID/started with symptoms, fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (tested positive for COVID/started with symptoms, fever). At the time of the report, COVID-19 (tested positive for COVID/started with symptoms, fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Dec-2021, SARS-CoV-2 test: positive (Positive) Result turned positive on 15-Dec-2021.         No concomitant medications were reported. No treatment medications were reported.  The patient recently made a trip.  On around 06-Dec or 07-Dec, the patient developed symptoms of COVID like fever. The patient wanted to know for how long do the patient have to wait to get the booster dose.  Company comment: This is a spontaneous case concerning a patient with no reported medical history, who experienced the unexpected, non-serious, AESI event of Covid-19. The event Covid-19 occurred approximately 286 days after the second dose of mRNA-1273 vaccine administration with positive Covid-19 test result. No reported treatment information. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient with no reported medical history, who experienced the unexpected, non-serious, AESI event of Covid-19. The event Covid-19 occurred approximately 286 days after the second dose of mRNA-1273 vaccine administration with positive Covid-19 test result. No reported treatment information. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
I had my vaccination on 07/31/2022. On 10/02/2022 I started to have some chills sore throat and sneezing. I took a COVID-19 test and it was negative. On 10/03/2022 I tested COVID-19 Positive.
Since receiving the second vaccine I have lost all taste and smell.  Has bot returned in 3 months
I have been feeling kind of tired and mentally fuzzy, sort of just cloudy and still tired; I have been feeling kind of tired and mentally fuzzy, sort of just cloudy and still tired; I don't feel so great, I feel kind of just not great; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 07May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: FATIGUE (non-serious), FEELING ABNORMAL (non-serious) all with onset 07May2021, outcome "not recovered" and all described as "I have been feeling kind of tired and mentally fuzzy, sort of just cloudy and still tired"; MALAISE (non-serious) with onset 07May2021, outcome "not recovered", described as "I don't feel so great, I feel kind of just not great".  Additional information: Consumer stated that got the vaccine, the first time on Friday, and have been feeling kind of tired and mentally fuzzy, sort of just cloudy and still tired. Patient was wondering, patient didn't feel so great, feel kind of just not great but Patient didn't feel really terrible in the sense of any kind of pain or anything extreme.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
low temperature (94.4) and chills  I normally run around 96.8 - 97, but 94.4 seemed too low. I teach and our school nurse suggested I complete this form.
Eyes rolled back in head and quit breathing around 8:00 PM (per grandmother). To ER, intubated/ventilator. Transferred to another hospital. Temp 105.   Nurse follow up on 08/30/04 states: "Complete."
Seizure - The patient was evaluated with a CT scan with a possible parafalcine mass.  MRI of the brain showed that there is slowly increasing size meningioma.  Neurology was consulted and advised about loading dose of Keppra followed by maintenance.  The patient was covered with medication no more seizures in the hospital.  She was back to her baseline. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
When I had itching jont pain had Bad Bruising on my Breast chills vonting head hurt all tim cant stop Keep Blader linking musler pain spitting mucus up
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 71-year-old male patient who received Shingrix (batch number 7X3EJ, expiry date 13th October 2020) for prophylaxis. On 23rd August 2018, the patient received the 1st dose of Shingrix (intramuscular). In September 2018, 21 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unchanged. It was unknown if the reporter considered the rash to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix in the left deltoid. Three weeks after receiving Shingrix, the patient experienced a rash on both legs below their knees.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about patient's pertinent medical histories, concomitant medications, drug reactions or allergies provided. On unknown dates, the patients were vaccinated with improperly stored GARDASIL (lot # J002641, expiration date 10-DEC-2015; lot# J008423, expiration date 21-JAN-2016; lot # J013324 expiration date 12-FEB-2016; lot # J006236, expiration date 25-FEB-2016; lot # J009788, expiration date 17-MAR-2016; lot # J006850, expiration date 31-MAR-2016, doses, route and site of administration were not reported). There were no adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested.
Aches; This spontaneous report received from a parent concerned a male of unspecified age. The patient's height, and weight were not reported.  The patient's concurrent conditions included penicillin allergy, and anaphylactic shock when expose to penicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry date: unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. the batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of aches was not reported. This report was non-serious. This case, from the same reporter is linked to 20210347232. .  .
REDNESS, SORENESS AT/AROUND SITE.  HARD AND WARM. STILL ABOUT THE SAME SYMPTOMS 10 DAYS LATER.  NO TREATMENT WAS ADMINISTERED.
First dose / 31-October-2021 / has not received / second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose(0.5ml) received on 31st October 2019, by intramuscular route).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of vaccination the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient had not received her second dose but was planning to. The reporter did not consent to follow up with her MD. The VAERS details were reported for 1st dose of Shingrix
Headache, chills for 10 hours, dry mouth, left arm slight swelling had to remove my fit bit and rings for 24 hours, tired 36 hours, blister on roof of mouth finally going away (day three),
I had my vaccination on 11/2022. In 02/15/2023 I was newly diagnosed with Type 1.5 Diabetes. Latent autoimmune diabetes in adults. I started insulin treatments during this time.
Not an adverse effect, but wrong vaccine administered.  Patient received original COVID Pfizer vaccine instead of the bivalent vaccine.
I had off and on vertigo and Tinnitus after my COVID-19 shots. It could have always been there I am not sure. It has not impacted my hearing. I have had it tested. Recently, I had headache and nose congestion, it was really bad vertigo at first. I tend to get that first when I get sick. It was pain in my face along with the headache. I contacted my doctor yesterday the infection was not going away after trying to treat it on my own. I took two COVID-19 home tests that were negative. I got to an appointment and prescribed amoxicillin and another antibiotic. I still feel it in my face and nose, but the sinus infection is getting better.
Per History and Physical written 12/13/21: Patient is a 72 y.o. male with a past medical history significant for essential hypertension, GERD and Hyperlipidemia presents to the ED with complaints of ongoing shortness of air and fatigue.  Patient reports he was diagnosed with COVID 19 at Hospital last week but he is unsure as to the date. However he reports his symptoms have been ongoing for 8 days or longer.  He notes that him and his wife developed symptoms around the same time two weeks ago.  I spoke to his wife by phone and she confirms they both tested positive two weeks ago and both received monoclonal antibodies at Hospital.  Since then his symptoms have not improved.  He continues to have shortness of air, non-productive cough, nausea, diarrhea, fatigue and body aches.  He did receive J&J Vaccine but has yet to receive his booster shot.  Patient denies any chest pain, palpitations, abdominal pain, dysuria, hematuria or melena.  CTA of chest obtained tonight reveals multifocal bilateral pneumonia, greater on the right.  Large hiatal hernia.  No evidence of pulmonary embolism.  Patient will be admitted to Hospital under the care of the Hospitalist for further evaluation and treatment.
6 hours after receiving  fluzone high dose vaccination had a 2 to 3 hours asthma attack. Patient recovered after the 2 to 3 hours.
Wwelt size of a nickel, area red with itching.  Reaction occurred am of 3/8/08.
first signs and symptoms for COVID; body aches; sick; This is a spontaneous report from a contactable consumer (parent). This consumer reported that an 18-year-old female patient (consumer's daughter) received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 07Aug2021 (age 18-year-old at the time of vaccination) as DOSE 1, SINGLE for covid-19 immunisation. The medical history included asthma from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The reporter (parent) called for her 18-year-old daughter with asthma who received her first dose of the Pfizer COVID Vaccine on 07Aug2021 and showed her first signs and symptoms for COVID on 14Aug2021. She mentioned that she had body aches and other symptoms that made her sick on 14Aug2021 but did not require hospitalization. She mentioned that she seems to be okay and was herself with no symptoms as of now. She mentioned that they have also completed isolation. Her daughter was due for her second dose on 28Aug2021. She was asking when the best time for someone was who had COVID to get the vaccine's second dose because their doctor and the daughter's physician told them different things. The Physician told them to wait 60 days in which she mentioned differed from what she knew was the 42-day maximum interval. She also mentioned that some guidelines told them to wait 90 days given that people who received an infection are more protected. She wanted to know the guidance from Pfizer. Caller disconnected before survey was offered. The outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reported by a member of the public that child received flu vaccine at school-based clinic without parental signature on form. Nurse reviewed all documents from clinic and found one form that had been filled out, send into the school, but not signed by a parent/guardian.  Call to mother of child by Public Health Director x2; voicemail left for her to call us back.
4 vaccines administered. Pt fainted after last vaccine. Reclined on cot, ice to face, BP=12/74, P:76 R=20. Recovered, color good, alert, oriented after 5 min. 8:10 forehead, reddened and swollen lips and nose swollen. Frequent congested cough. 911 called for possible allergic reaction, Epi-pen 0.3mg admin 8:15.
Left deltoid swelling & redness.  3 X 4 cm mild induration.
Td and HAV given in LDT. Mother of child noted swelling and redness the next day 8/14/03. Noted by doctor in clinic red rash, mild swelling, tenderness without warmth, pain with shoulder elevation. 8/15/03 pt returned to clinic for redness with warmth to the touch, but less swelling. States harder to touch. LDT 5.5cm x 8cm oval area of redness around site.
Started running fever on day of vaccine. Complained of chest being sore. Fever came down with meds. Had OK appetite. Thur. off & on mention of discomfort. Fri said better. Fever returned that night. Sat. AM he complained of pain and accelerated. Went to hospital (a.m). We will never allow FLUMIST again. This resulted in $900.00 that we have not to spend out of pocket. My son was scared - we were scared for him. My children are rarely sick and do not see a doctor often for illness. This was unacceptable.
1st dose a year ago, 2nd not received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose over a year ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. The action taken with Shingrix was unknown. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 22-Dec-2022 Reporter's comment: The reporter asked about vaccination date for first dose but did not had it because it was at a different pharmacy, did not had information on batch nor expiration date either because of same reason. Second dose has not been administered. The reporter consented to follow-up via email. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.